Refactor Capital
Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments
Ashwin Nandakumar and Ashwin Jainarayanan were working on their doctorates at adjacent departments in Oxford, but they didn’t know each other. Nandakumar, who was studying oncology, one day stumbled across…
Zal Bilimoria just raised a $50M fourth Refactor Capital fund, and still relishes his solo GP status
Being a solo GP hasn’t slowed Bilimoria a bit. He went on to raise three additional funds and has now closed a new fund to invest in biotech, climate and…
The company’s pilot program showed that farms are able to generate 10 to 20 times more protein per acre and use five to 10 times less water than other crops,…
The success of CRISPR technology in agriculture has been well documented as a way to manipulate plant genomes to make them more pest and climate resistant and grow more consistent…
Ali Amin-Javaheri grew up in the chemicals business. His father had worked for Iran’s state-owned chemical company and when the family fled the country in the nineteen eighties during the…
This young litigation finance startup just secured $100 million to chase cases it thinks will win
If you haven’t heard much about litigation finance, that may change soon. The practice dates back decades, though it’s been picking up momentum since 2006, when Credit Suisse Securities founded…
Not everyone gets a second chance in Silicon Valley. Entrepreneur Hosain Rahman has been given many more than that. Though his last company, Jawbone, which produced wireless speakers and Bluetooth…
Mint founder Aaron Patzer launches Vital, an ER management tool that integrates with electronic health records
Aaron Patzer launched Mint to help consumers organize their finances. Now he’s raised $5.2 million from investors to launch Vital to bring that consumer-focused mindset to emergency rooms and hospitals…
With a clinical version of PathAI‘s computer vision-based pathology detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in its…
Biomanufacturing technologies — taking modified versions of existing organisms and bending them to the will of humans — has moved from the world of science fiction to becoming a new…
Companies tracking mutations in cancer cells can provide a key to unlocking better therapies
Investors and entrepreneurs are beginning to bring new diagnostic tools to market that promise better results for cancer patients through the identification of mutations in cancer cells that can create…
Five years ago, we told you about a venture capital auction wherein dozens of VCs donated their time toward a greater good — helping fund research at the Leukemia &…
Going to the dentist can be anxiety-inducing. Unfortunately, it was no different for me last week when I went to discuss Uniform Teeth’s recent $4 million seed funding round from…
There’s a new entrant in the race to provide internet connectivity to the roughly four billion humans on the wrong side of the world’s digital divide. Launching from stealth today…
The FDA approval process can be like navigating a minefield for health startups hoping to get through regulations and begin selling to the American public. YC company Enzyme.io hopes to…
Trace Genomics launches a 23andMe for farms, raises $4 million to improve the world’s food supply
A San Francisco startup called Trace Genomics wants to help farmers diagnose and improve the health of the soil where they want to raise crops before it’s harvest time and…
David Lee, a former Google executive who for several years ran the seed-stage venture fund SV Angel, is back with his own new firm, shows an SEC filing. The outfit is…
